Related Experiment Video

Updated: Aug 11, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway

Jean-Cheng Kuo1, Won-Jing Wang, Chung-Chen Yao

  • 1Institute of Molecular Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 106, Taiwan.

The Journal of Cell Biology
|February 16, 2006
PubMed

Insights

Death-associated protein kinase (DAPK) inhibits tumor cell migration and invasion by blocking cell polarization. This apoptosis-independent activity reveals a novel mechanism for DAPK

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Death-associated protein kinase (DAPK) is a serine/threonine kinase known for its roles in apoptosis and tumor suppression.
  • The precise mechanisms by which DAPK suppresses tumors, particularly independent of apoptosis, remain incompletely understood.

Purpose of the Study:

  • To investigate the apoptosis-independent functions of DAPK in regulating tumor cell migration and invasion.
  • To elucidate the molecular pathways through which DAPK exerts its antimigratory effects.

Main Methods:

  • Assessed the impact of DAPK on random and directed cell migration.
  • Investigated DAPK's role in cell polarization and the integrin-Cdc42 signaling pathway.
  • Utilized an adenocarcinoma cell line and its invasive derivative to correlate DAPK levels with tumor invasiveness.

Main Results:

  • DAPK inhibits random cell migration by reducing directional persistence and directed migration by blocking cell polarization.
  • DAPK's antimigratory effects are mediated by inhibiting talin head domain association with integrin, thus suppressing the integrin-Cdc42 polarity pathway.
  • DAPK effectively blocks migration and invasion in apoptosis-resistant tumor cells, and DAPK levels correlate with tumor invasiveness.

Conclusions:

  • DAPK possesses a novel apoptosis-independent function in suppressing tumor progression by regulating cell polarity during migration.
  • This antimigratory function, alongside its apoptotic role, contributes to DAPK's overall tumor-suppressive capabilities.
  • DAPK's regulation of cell migration and polarity presents a potential therapeutic target for inhibiting tumor invasion and metastasis.

More Related Videos

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...